Pfizer discontinues development of danuglipron for chronic weight management Ruchika Sharma14 April 2025 5:41 PM ISTNew York: Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like...
Sun Pharma eyes to launch obesity drug in five years: MD Ruchika Sharma1 March 2025 2:34 PM ISTMumbai: Pharma major, Sun Pharmaceutical, is gearing up to introduce its experimental anti-obesity and type 2 diabetes medicine in the next...
Eli Lilly Collaborates with Laekna to Develop Obesity Drug Targeting Muscle Preservation and Weight Loss Farhat Nasim24 Nov 2024 11:00 AM ISTBengaluru: Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients lose weight while...
Novo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients Farhat Nasim20 Nov 2024 1:36 PM ISTThe move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has yet to launch it.
Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO Ruchika Sharma11 May 2024 11:30 AM ISTBengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their...
Ozempic not linked to increase in suicidal thoughts: US study Roshni Dhar12 Jan 2024 4:56 PM ISTA recent U.S. federal study funded by the National Institutes of Health (NIH) and conducted by Case Western Reserve University reveals that...
Patients to stay on Wegovy longer than older weight loss drugs, expects Novo Nordisk CEO Ruchika Sharma11 Jan 2024 4:30 PM ISTThe Danish drugmaker's chief executive said the effects patients see after being on Wegovy would be an incentive for them to continue, although it may...
Roche joins race for obesity drugs with USD 2.7 billion Carmot deal Ruchika Sharma5 Dec 2023 1:30 PM ISTRoche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to...
Novo Nordisk to launch popular anti-obesity drug Wegovy in Japan Ruchika Sharma25 Nov 2023 4:41 PM ISTThe monthly cost for patients will be 7,504 Japanese yen ($50.15) for a 0.25-milligram starter dose and 42,960 yen for a 2.4 mg dose, Novo said.
Anti obesity drugs can shrink more than patients Roshni Dhar25 Sept 2023 2:48 PM ISTStarry-eyed venture capitalists love to talk about how promising startups might capture a chunk of a giant total addressable market (TAM). This...
Health Bulletin 23/September/2023 Roshni Dhar23 Sept 2023 5:08 PM ISTHere are the top health stories for the day:NEET SS 2023 admit card outThe National Board of Examinations (NBE) has released the admit card for NEET...
Breakthrough obesity drug may allow unlimited eating without weight gain Roshni Dhar5 Sept 2023 5:46 PM ISTResearchers led by Director C. Justin LEE from the Center for Cognition and Sociality (CCS) within the Institute for Basic Science (IBS) have...
